Specialists for Embryonal carcinoma of the central nervous system

16 physicians and care centers identified from ClinicalTrials.gov trial PIs, PubMed publications, and the NPPES NPI registry.

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Tab Cooney, MD, M.D
Rare Disease / Clinical Research
Tango Therapeutics, Inc.
BOSTON, MA
QC-verified PI×1
Amanda Olson
Rare Disease / Clinical Research
M.D. Anderson Cancer Center
PI×2 19
Robert J. Motzer, MD, MD
Rare Disease / Clinical Research
Memorial Sloan Kettering Cancer Center
NEW YORK, NY
PI×14
Jeremie Calais, MD
Rare Disease / Clinical Research
UCLA / Jonsson Comprehensive Cancer Center
LOS ANGELES, CA
PI×4
Monica Loghin, M.D
Rare Disease / Clinical Research
M.D. Anderson Cancer Center
HOUSTON, TX
PI×1
Sanjiv Gambhir, MD, PhD
Rare Disease / Clinical Research
Stanford University
PI×2
Scot C. Remick, MD, MD
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center
PI×10
Sebastien Hotte
Rare Disease / Clinical Research
University Health Network-Princess Margaret Hospital
PI×1
Lauren Abrey, MD, MD
Rare Disease / Clinical Research
National Cancer Institute (NCI)
NEW YORK, NY
PI×1 1
Jing Li
Rare Disease / Clinical Research
M.D. Anderson Cancer Center
PI×2 1557
Paul B. Chapman, MD
Rare Disease / Clinical Research
Memorial Sloan Kettering Cancer Center
PI×3
Philip Wong, MD, FRCPC
Rare Disease / Clinical Research
Centre hospitalier de l'Université de Montréal (CHUM)
PI×1
Maxim Pimkin, MD, PhD, MD, PhD
Rare Disease / Clinical Research
Tango Therapeutics, Inc.
PITTSBURGH, PA
PI×1
Du Lam, MD
Rare Disease / Clinical Research
Celgene
PI×1
Luigi Naldi, MD
Rare Disease / Clinical Research
Centro Studi Gised
PI×2 1
Thomas F Hack
University of Manitoba
PI×1

More about Embryonal carcinoma of the central nervous system